FERA AT THE FOREFRONT 
 
 
The management team at Fera has been handpicked to embody the values and vision of the company.  Each member is committed to making Fera your go-to resource and responsive partner in quality specialty pharmaceuticals.
  • Deep experience in eye care and other specialty pharmaceutical markets 
  • Expertise in acquiring, licensing, developing and commercializing products that address underserved medical and human needs 

A management team for the 21st century

The experience and energy to expand choices in specialty pharmaceuticals

The senior leadership at Fera has a proven track record for identifying often overlooked opportunities in specialty markets—and bringing much-needed, cost-effective treatments to fruition. We’ve brought together a team with extensive, yet specialized, pharmaceutical industry experience; one that has particular expertise in generics, eye care and other specialty arenas. And our sights are set on great things.


Co-founders

Janet DellaFera Frank J. DellaFera and Janet DellaFera
The formation of Fera Pharmaceuticals is the realization of a lifelong dream of co-founders Frank and Janet DellaFera. It’s the culmination of their life’s work. They are proud to establish this one-of-a-kind specialty pharmaceutical company to meet many of the needs left unaddressed by today’s larger companies and global conglomerates.

Frank J. DellaFera

Prior to building Fera Pharmaceuticals, Frank held the esteemed position of CEO and President of Sandoz US, one of the world’s largest and most successful generic pharmaceutical companies. Before his appointment to CEO at Sandoz US, he served as Vice President, Sales and Marketing for the organization. From 1996 to 2005, Frank was Vice President, Sales and Marketing at Eon Labs, which was acquired by Sandoz. Earlier in his career, Frank held several sales and marketing positions, including Senior Regional Sales Director for Dura Pharmaceuticals. Additionally, Frank served in management and business development capacities for Ben Venue Laboratories, Inc. and American Regent Laboratories Inc. He began his career at Eli Lilly and Company as a field sales representative, where he was promoted to Hospital Sales Specialist. Frank received a B.S. degree in Pharmacy from the College of Pharmacy, St. John’s University.


Marketing

Susan McDougal Susan McDougal
Susan has over 20 years of healthcare marketing experience, both in branded and generic pharmaceuticals. She was a Senior Marketing Manager for Sandoz, one of the largest generic pharmaceutical companies in the US where she was responsible for the management and promotional support of a diverse portfolio of products. She began her career in generic marketing as a Marketing Manager at Eon Labs, one of the fastest growing generic pharmaceutical companies in the industry prior to the Sandoz acquisition. Before joining Eon, Susan was a Group Account Supervisor at Sudler & Hennessey, where she employed her skills in both media planning and account management to support various pharma clients’ communication needs. She received a B.S. degree in Business Management and Economics from St. John’s University.

Regulatory Affairs


John G. D’Angelo
John is a Registered Pharmacist and has over 30 years of experience in the pharmaceutical, medical device, OTC, dietary supplement and nutritional product industries. Most recently he was Senior Director of Regulatory Affairs at Nycomed US. John also served as Vice President of Regulatory Affairs at Leiner Health Products, Medtronic MiniMed, B. Braun Medical as well as Sterling Drug Inc . His experience and responsibilities include oversight of the Regulatory, Quality, Compliance, Clinical Research and New Product Development functions at the corporate level. John has been responsible for submissions to the U.S. FDA, Health Canada and European Union for approval. He has had product experience in aseptically filled drug delivery systems, terminally sterilized parenteral products solid oral dosage forms and software controlled medical devices. His areas of expertise include Prescription Drugs (INDs, NDAs, ANDAs), OTC Drugs (Monograph and ANDAs), Medical Devices (IDEs, / PMAs, 510(k)s), Dietary and Nutritional Supplements, Combination Drug and Device Products and Medical Foods.


Business Development

Scott Florentino
Scott has over 13 years of experience in the pharmaceutical industry. His pharmaceutical career started in sales promoting a broad range of Pfizer products in the office and institutional settings. Before joining Fera he worked at Pedinol Pharmacal, Inc. a specialty pharmaceutical company focused on podiatry. Scott started at Pedinol as a Product Manager for various pharmaceutical, OTC and in-office procedure products. With a promotion to Manager of Commercial Development, Scott drove Pedinol’s business, product and corporate development initiatives. Scott has an undergraduate degree from Pennsylvania State University and an MBA from Hofstra University.


Product Development



Stephanie Tremonte
Stephanie is a Registered Pharmacist and has over 15 years experience in the pharmaceutical industry. She spent over 13 years at Teva Pharmaceuticals in various R&D roles of increasing responsibility. Most recently, she was Director of US Generic Portfolio Optimization where she was responsible for the selection, prioritization and management of the US pipeline. In addition, she gained branded pharmaceutical experience during her time at Barrier Therapeutics where she held roles as Clinical Project Leader and Director of Medical Marketing. Throughout her career she has gained expertise in many aspects of research and development across all therapeutic areas with an emphasis on bioequivalence/pharmacokinetics, formulation development and project and portfolio management. Stephanie received a B.S. degree in Pharmacy from Ohio Northern University and an M.S. in Quality Assurance & Regulatory Affairs from Temple University

Quality and Manufacturing

Philip Hammer
Phil has almost 30 years experience in the pharmaceutical industry. Prior to joining Fera, Phil was the Sterile Manufacturing Manager for Nycomed US where he managed the aseptic manufacturing of ophthalmic ointments, ophthalmic solutions and parenterals. His experience encompasses all aspects of sterile pharmaceutical operations including establishing, validating and operating aseptic facilities. In addition, he has worked with some of the world’s largest pharmaceutical companies, managing technical transfers of contract manufactured sterile products. Previously he worked in the manufacturing of non-sterile topical creams, ointments and lotions. Phil has certifications in sterile filtration, isolator barrier technology, sterilization processes and clean room management.

Finance


Rosanna Santoro, CPA
Rosanna brings over 30 years of experience in finance and accounting to her position at Fera Pharmaceuticals.  She began her accounting career at Long Island Lighting Company as a financial and tax analyst and later moved on to public accounting broadening her experience.  Over the years, she has successfully managed a private accounting practice and was the Controller for small businesses in various industries, including professional firms, law, retail, and real estate management.  Rosanna joined Fera Pharmaceuticals as Controller in August 2015. Rosanna graduated Summa Cum Laude from C.W. Post Center, Long Island University.  Upon graduation, she successfully passed all four sections of the CPA exam.  Rosanna is a current member of the American Institute of Certified Public Accountants.